MIM
ABBV icon

Montgomery Investment Management’s AbbVie ABBV Stock Holding History

Montgomery Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.28M Hold
13,045
– – 1% 26
2026
Q1 		$2.84M Hold
13,045
– – 0.97% 27
2025
Q4 		$2.98M Hold
13,045
– – 1.07% 27
2025
Q3 		$3.02M Hold
13,045
– – 1.06% 26
2025
Q2 		$2.42M Hold
13,045
– – 0.94% 28
2025
Q1 		$2.73M Buy
13,045
+40
+0.3% +$7.78K 1.09% 26
2024
Q4 		$2.31M Sell
13,005
-20
-0.2% -$3.68K 0.91% 29
2024
Q3 		$2.57M Hold
13,025
– – 0.93% 27
2024
Q2 		$2.23M Sell
13,025
-70
-0.5% -$11.6K 0.88% 28
2024
Q1 		$2.38M Sell
13,095
-2,430
-16% -$419K 0.91% 25
2023
Q4 		$2.41M Sell
15,525
-89
-0.6% -$13K 0.74% 29
2023
Q3 		$2.33M Hold
15,614
– – 0.8% 28
2023
Q2 		$2.1M Sell
15,614
-670
-4% -$98.3K 0.71% 30
2023
Q1 		$2.6M Sell
16,284
-40
-0.2% -$6.12K 0.92% 28
2022
Q4 		$2.64M Sell
16,324
-52
-0.3% -$7.97K 0.94% 28
2022
Q3 		$2.2M Hold
16,376
– – 0.9% 28
2022
Q2 		$2.51M Sell
16,376
-710
-4% -$108K 1.01% 28
2022
Q1 		$2.77M Hold
17,086
– – 0.95% 28
2021
Q4 		$2.31M Sell
17,086
-320
-2% -$37.8K 0.78% 31
2021
Q3 		$1.88M Buy
17,406
+530
+3% +$60.6K 0.7% 33
2021
Q2 		$1.9M Sell
16,876
-1,600
-9% -$180K 0.71% 31
2021
Q1 		$2M Hold
18,476
– – 0.77% 31
2020
Q4 		$1.98M Hold
18,476
– – 0.91% 28
2020
Q3 		$1.62M Sell
18,476
-300
-2% -$28.2K 0.85% 29
2020
Q2 		$1.84M Sell
18,776
-360
-2% -$31.7K 1% 28
2020
Q1 		$1.46M Hold
19,136
– – 0.95% 30
2019
Q4 		$1.7M Hold
19,136
– – 0.69% 36
2019
Q3 		$1.45M Hold
19,136
– – 0.62% 39
2019
Q2 		$1.39M Hold
19,136
– – 0.61% 41
2019
Q1 		$1.54M Hold
19,136
– – 0.69% 41
2018
Q4 		$1.76M Sell
19,136
-900
-4% -$79.1K 0.9% 34
2018
Q3 		$1.9M Hold
20,036
– – 0.78% 39
2018
Q2 		$1.86M Buy
20,036
+221
+1% +$21.6K 0.76% 38
2018
Q1 		$1.88M Hold
19,815
– – 0.79% 36
2017
Q4 		$1.92M Sell
19,815
-275
-1% -$25.9K 0.78% 34
2017
Q3 		$1.79M Hold
20,090
– – 0.79% 36
2017
Q2 		$1.46M Hold
20,090
– – 0.67% 37
2017
Q1 		$1.31M Hold
20,090
– – 0.56% 41
2016
Q4 		$1.26M Buy
20,090
+200
+1% +$12.2K 0.54% 43
2016
Q3 		$1.25M Sell
19,890
-100
-0.5% -$6.47K 0.59% 41
2016
Q2 		$1.24M Sell
19,990
-1,000
-5% -$60.9K 0.6% 40
2016
Q1 		$1.2M Sell
20,990
-600
-3% -$33.4K 0.69% 38
2015
Q4 		$1.28M Sell
21,590
-300
-1% -$17.3K 0.72% 35
2015
Q3 		$1.19M Hold
21,890
– – 0.7% 32
2015
Q2 		$1.47M Sell
21,890
-600
-3% -$39.2K 0.75% 32
2015
Q1 		$1.32M Hold
22,490
– – 0.66% 37
2014
Q4 		$1.47M Buy
22,490
+1,600
+8% +$101K 0.7% 36
2014
Q3 		$1.21M Buy
20,890
+800
+4% +$44.4K 0.83% 31
2014
Q2 		$1.13M Sell
20,090
-567
-3% -$29.7K 0.87% 28
2014
Q1 		$1.06M Sell
20,657
-400
-2% -$20.2K 0.86% 27
2013
Q4 		$1.11M Sell
21,057
-13,567
-39% -$667K 0.91% 29
2013
Q3 		$1.55M Hold
34,624
– – 0.84% 36
2013
Q2 		$1.43M Buy
+34,624
New +$1.51M 0.78% 38

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Montgomery Investment Management's ABBV Position: Q2 2026 in Review

Montgomery Investment Management held its AbbVie (ABBV) position steady in Q2 2026 at 13,045 shares worth $3.28M. The position accounts for 1% of the portfolio, ranked #26.

Montgomery Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Montgomery Investment Management held 13,045 shares of AbbVie worth $3.28M as of Q2 2026.
  • Montgomery Investment Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 1% of Montgomery Investment Management's portfolio in Q2 2026, its #26 holding.
  • Montgomery Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Montgomery Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.